Volume 10 - Issue 6 - June 2010
06/02/2010
David H. Fater, CEO of Vicor Technologies, Inc., announced the initial results of a study designed to analyze data from the Merte Subita en Insufficiencia Cardiaca (MUSIC) Trial using itsPD2i®algorithm and software. VicorTechnologiesis a...
David H. Fater, CEO of Vicor Technologies, Inc., announced the initial results of a study designed to analyze data from the Merte Subita en Insufficiencia Cardiaca (MUSIC) Trial using itsPD2i®algorithm and software. VicorTechnologiesis a...
David H. Fater, CEO of Vicor...
06/02/2010
EP Lab Digest
06/02/2010
In order to be successful, organizations need to make a strong commitment toward physician recruitment. In this feature article, author Jessica Barrick provides insight into how your organization can be perceived by potential...
In order to be successful, organizations need to make a strong commitment toward physician recruitment. In this feature article, author Jessica Barrick provides insight into how your organization can be perceived by potential...
In order to be successful,...
06/02/2010
EP Lab Digest
06/02/2010
Cameron Health, Inc. announced the publication of study results online in the New England Journal of Medicine (NEJM) highlighting the development and potential benefits of the company’s S-ICD® System, the first minimally invasive,...
Cameron Health, Inc. announced the publication of study results online in the New England Journal of Medicine (NEJM) highlighting the development and potential benefits of the company’s S-ICD® System, the first minimally invasive,...
Cameron Health, Inc....
06/02/2010
EP Lab Digest
06/02/2010
St. Jude Medical, Inc. and iRhythm Technologies, Inc., a privately-held company, announced they have entered into partnership with a focus on iRhythm’s ZioTM Patch. iRhythm also announced closure of a $10 million private equity round of...
St. Jude Medical, Inc. and iRhythm Technologies, Inc., a privately-held company, announced they have entered into partnership with a focus on iRhythm’s ZioTM Patch. iRhythm also announced closure of a $10 million private equity round of...
St. Jude Medical, Inc. and...
06/02/2010
EP Lab Digest
06/02/2010
AtriCure, Inc. announced that it has received conditional approval from the FDA to evaluate the safety and efficacy of a dual epicardial/endocardial procedure (DEEP), or hybrid procedure, to treat patients with persistent and long-standing...
AtriCure, Inc. announced that it has received conditional approval from the FDA to evaluate the safety and efficacy of a dual epicardial/endocardial procedure (DEEP), or hybrid procedure, to treat patients with persistent and long-standing...
AtriCure, Inc. announced that...
06/02/2010
EP Lab Digest
06/02/2010
Biosense Webster, Inc. announced the completion
of the first clinical cases with the new ® THERMOCOOL SF Irrigated Ablation catheter in the European Union, following recent CE Mark approval. The THERMOCOOL® SF catheter is the most advanced...
Biosense Webster, Inc. announced the completion
of the first clinical cases with the new ® THERMOCOOL SF Irrigated Ablation catheter in the European Union, following recent CE Mark approval. The THERMOCOOL® SF catheter is the most advanced...
Biosense Webster, Inc....
06/02/2010
EP Lab Digest
06/02/2010
Hansen Medical, Inc. announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food & Drug Administration (FDA) authorizing a clinical trial to investigate use of the Sensei® X Robotic...
Hansen Medical, Inc. announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food & Drug Administration (FDA) authorizing a clinical trial to investigate use of the Sensei® X Robotic...
Hansen Medical, Inc....
06/02/2010
EP Lab Digest
06/02/2010
Medtronic, Inc. released new data from the MVP (Managed Ventricular Pacing) trial that implantable defibrillator patients receiving anti-tachycardia pacing (ATP) were less likely to have health care utilization after treatment as compared...
Medtronic, Inc. released new data from the MVP (Managed Ventricular Pacing) trial that implantable defibrillator patients receiving anti-tachycardia pacing (ATP) were less likely to have health care utilization after treatment as compared...
Medtronic, Inc. released new...
06/02/2010
EP Lab Digest
06/02/2010
nContact Surgical, Inc. (nContact) announced it has enrolled the first patient in its IDE trials to evaluate a fully closed chest procedure combining the best of electrophysiologist (EP) catheter and surgical techniques for the treatment...
nContact Surgical, Inc. (nContact) announced it has enrolled the first patient in its IDE trials to evaluate a fully closed chest procedure combining the best of electrophysiologist (EP) catheter and surgical techniques for the treatment...
nContact Surgical, Inc....
06/02/2010
EP Lab Digest
06/02/2010
Stereotaxis, Inc. announced the introduction of its new VdriveTM, an expansion of its Magnetic Navigation platform that facilitates remote manipulation of diagnostic devices used during EP procedures. The Vdrive will be commercially...
Stereotaxis, Inc. announced the introduction of its new VdriveTM, an expansion of its Magnetic Navigation platform that facilitates remote manipulation of diagnostic devices used during EP procedures. The Vdrive will be commercially...
Stereotaxis, Inc. announced...
06/02/2010
EP Lab Digest
